Sciformix Corporation Revenue and Competitors

Location

$1.3M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Sciformix Corporation's estimated annual revenue is currently $79.8M per year.(i)
  • Sciformix Corporation's estimated revenue per employee is $269,584
  • Sciformix Corporation's total funding is $1.3M.

Employee Data

  • Sciformix Corporation has 296 Employees.(i)
  • Sciformix Corporation grew their employee count by -2% last year.

Sciformix Corporation's People

NameTitleEmail/Phone
1
COOReveal Email/Phone
2
Functional Safety Manager (SME)Reveal Email/Phone
3
Team ManagerReveal Email/Phone
4
ManagerReveal Email/Phone
5
Work Flow Manager, PharmacovigilanceReveal Email/Phone
6
Labelling LeadReveal Email/Phone
7
Director- Domain and Process, Safety and Risk ManagementReveal Email/Phone
8
Lead, Submission-Pharmacovigilance OperationReveal Email/Phone
9
Senior Domain Lead, Aggregate Safety and Risk ManagementReveal Email/Phone
10
Junior Safety Data AnalystReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is Sciformix Corporation?

Sciformix is a US headquartered Knowledge Process Outsourcing company whose aim is to deliver high quality knowledge-based services using a cost-optimized global delivery model. The company relies on the collective contributions of its experienced Leadership Team and its prestigious Scientific Advisory Board to deliver specialized services of the highest quality in global Drug Safety Data Management, Clinical Data Management, Biostatistics and Medical Writing.

keywords:N/A

$1.3M

Total Funding

296

Number of Employees

$79.8M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$58.6M29628%N/A
#2
$53.4M305-7%N/A
#3
$95.6M306-16%N/A
#4
$56.5M3077%$132.3M
#5
$35M30910%N/A